Assessment of glomerular filtration rate based on alterations of serum brain-derived neurotrophic factor in type 2 diabetic subjects treated with amlodipine/benazepril or valsartan/hydrochlorothiazide.
Conclusions. Increased serum BDNF is associated with reduced eGFR in type 2 diabetic subjects treated with valsartan/hydrochlorothiazide but not with amlodipine/benazepril.
PMID: 25918454 [PubMed - in process]
Source: Disease Markers - Category: Laboratory Medicine Tags: Dis Markers Source Type: research
More News: Benazepril | Brain | Clinical Trials | Diabetes | Diabetes Type 2 | Diovan | Endocrinology | Hydrochlorothiazide | Hypertension | Laboratory Medicine | Lotrel | Neurology | Norvasc | Reflex Sympathetic Dystrophy | Study